Funding Details
- Awarder
- StartEngine
- Date Award
- June 13, 2024
- Vertical
- Healthcare
- Funding URL
- View Funding Page
- Premoney Valuation
-
$1,000,000
- Valuation
-
$22,040,000
Company Info
- Founding Year
- Not provided
- Traction
- Pre-orders worth a potential value of over $2.5 million USD
- Organizations Involved
- Y Combinator, StartX
- Founders
- Liza Velarde, Alejandro Abarca, Juan Felipe Yee
- Company Description
- At Delee, they have created the CytoCatch™️ isolation platform and imaging system for early cancer detection and monitoring the effectiveness of applied treatments. Their technology enables the performance of a CTC blood-based assay, potentially revolutionizing cancer diagnosis and treatment optimization.
- Market
- Cancer Detection and Treatment Monitoring
- Location
-
Laredo,
TX,
US
- Coinvestors
- Y Combinator, StartX
Links